STANDARD BIOTOOLS INC.

LAB Net buying

CIK 0001162194 #3739 in the set updated 18 Sep 2026

Bought (120 mo)

$74.58M

out of their own pocket, the only kind of buying there is

Sold (120 mo)

$20.05M

$0.00 on a plan · $0.00 straight out of an exercise

Sold at will

$20.05M

40 of 40 sales

Net

+$54.53M

+$54.53M against sales at will

By person

34 insiders · 292 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Casdin Partners Master Fund, L.P. entity

Director

$42.56M (52)

—

+$42.56M

74,906,470

19.08%

$108.37M

—

LEVIN CAPITAL STRATEGIES, L.P. entity

10% owner

$20.05M (153)

—

+$20.05M

2,361,085

0.6014%

$3.42M

−81.9%

Levin Easterly Partners LLC entity

10% owner

—

$19.36M (27)

−$19.36M

6,919,863

1.76%

$10.01M

−43.5%

Caligan Partners LP entity

10% owner

$7.68M (18)

—

+$7.68M

7,797,454

1.99%

$11.28M

−7.0%

Casdin Eli

Director

$2.63M (3)

—

+$2.63M

5,797,388

1.48%

$8.39M

—

COLELLA SAMUEL D

Director

$491.52K (11)

—

+$491.52K

239,268

0.0609%

$346.17K

+869.3%

BARTHELEMY NICOLAS

Director

$288.49K (2)

$63.40K (1)

+$225.09K

389,261

0.0992%

$563.18K

+102.4%

Black Jeffrey G.

SVP & Chief Financial Officer

$193.58K (2)

—

+$193.58K

421,608

0.1074%

$609.98K

—

JOG VIKRAM

Chief Financial Officer

$135.31K (1)

—

+$135.31K

269,683

0.0687%

$390.18K

+4,429%

McPhail Steven

Chief Commercial Officer

$60.03K (1)

—

+$60.03K

78,203

0.0199%

$113.14K

+847.6%

JONES EVAN/ FA

Director

—

$49.51K (2)

−$49.51K

58,551

0.0149%

$84.71K

−9.2%

Mackay Sean

SVP & Chief Business Officer

—

$38.22K (3)

−$38.22K

1,480,823

0.3772%

$2.14M

+146.8%

Linthwaite Stephen Christopher

President & CEO

$492.03K (3)

$514.01K (1)

−$21.98K

328,473

0.0837%

$475.23K

+1,138%

Egholm Michael

President & CEO

—

$15.14K (3)

−$15.14K

6,137,704

1.56%

$8.88M

+20,359%

Kim Hanjoon Alex

Chief Financial Officer

—

$4.15K (3)

−$4.15K

2,534,859

0.6457%

$3.67M

+7,766%

Cox Troy

Director

—

—

—

475,702

0.1212%

$688.25K

—

Carey Thomas D.

Director

—

—

—

344,456

0.0877%

$498.36K

—

ELOI FENEL M

Director

—

—

—

335,299

0.0854%

$485.11K

—

Witney Frank

Director

—

—

—

309,978

0.0790%

$448.48K

—

HIBBS KATHY L

Director

—

—

—

236,836

0.0603%

$342.65K

—

Paya Carlos V

Director

—

—

—

126,844

0.0323%

$183.52K

—

Kreger Bradley Allen

SVP, Global Operations

—

—

—

119,157

0.0304%

$172.40K

—

Clague Laura

Director

—

—

—

104,791

0.0267%

$151.61K

—

Madaus Martin D

Director

—

—

—

104,111

0.0265%

$150.63K

—

Khadder Nicholas

SVP, Gen. Counsel & Secretary

—

—

—

100,480

0.0256%

$145.37K

+1,225%

Burbach Gerhard F

Director

—

—

—

96,827

0.0247%

$140.09K

—

McCracken Colin

Chief Commercial Officer

—

—

—

65,103

0.0166%

$94.19K

+6,639%

Colston Bill

Director

—

—

—

59,288

0.0151%

$85.78K

—

JONES PATRICK S

Director

—

—

—

23,087

0.0059%

$33.40K

—

Yow Mai Chan

See Remarks

—

—

—

19,705

0.0050%

$28.51K

+163.1%

Stankovic Ana K.

Director

—

—

—

18,563

0.0047%

$26.86K

—

Davis Jeremy Steven

SVP Chief Commercial Officer

—

—

—

14,657

0.0037%

$21.21K

—

LEE JENNIFER LING

See Remarks

—

—

—

6,716

0.0017%

$9.72K

+482.5%

YOUNG JOHN A

Director

—

—

—

5,849

0.0015%

$8.46K

+588.9%

Individual transactions

0

Nothing of that kind in this period.

What was left out

Form 4 filings counted 477

Amendments (4/A) skipped 9

Filings about a different issuer 0

Unreadable filings 0

Joint filings 123

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 0

Sales at will 40

Transactions with no price 0

Shares from compensation/vesting 125,583,022

Sales filed before the plan box existed 31

History held since 21 Oct 2016